ENDOGENA
Endogena is a biotech company that develops endogenous regenerative medicines to repair and regenerate tissues and organs. Endogena's approach has the potential of a paradigm shift to treat degenerative conditions related to ageing and genetic disorders. The company implements innovation in the field of regenerative medicine. Their science combines the latest developments in stem cell biology, AI, and expertise in small-molecule drug design to develop breakthrough treatments for degenerative diseases.
ENDOGENA
Social Links:
Industry:
Biotechnology Medical Therapeutics
Founded:
2016-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.endogena.com
Total Employee:
11+
Status:
Active
Contact:
415-433-2262
Email Addresses:
[email protected]
Total Funding:
29 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Q32 Bio
Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Employees Featured
Founder
Investors List
Rejuveron Life Sciences
Rejuveron Life Sciences investment in Series A - Endogena
DEFTA Partners
DEFTA Partners investment in Series A - Endogena
Rejuveron Life Sciences
Rejuveron Life Sciences investment in Series A - Endogena
DEFTA Partners
DEFTA Partners investment in Series A - Endogena
Official Site Inspections
http://www.endogena.com Semrush global rank: 3.87 M Semrush visits lastest month: 3.34 K
- Host name: 228.129.153.160.host.secureserver.net
- IP address: 160.153.129.228
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Endogena"
endogena therapeutics – endogena.com
Endogena Therapeutics is dedicated to developing new therapies that have a positive impact on patient health, and to serving patients, patient families and patient communities through …See details»
Endogena - Crunchbase Company Profile & Funding
Endogena is a biotech company that develops endogenous regenerative medicines to repair and regenerate tissues and organs. Endogena's approach has the potential of a paradigm shift to …See details»
Endogena Therapeutics, Inc. | LinkedIn
It was very inspiring to have Matthias Steger PhD, MBA, CEO of Endogena Therapeutics, Inc. speaking at our recent conference in Montreux on ¨Endogena Therapeutics – a novel drug …See details»
Endogena Therapeutics Company Profile 2024: Valuation, Funding ...
Endogena Therapeutics General Information Description. Developer of a clinical-stage biotech company intended to discover and develop endogenous regenerative medicines to repair and …See details»
Endogena Therapeutics, Inc. | LinkedIn
Endogena Therapeutics, Inc. | 2,378 followers on LinkedIn. endogena’s mission is to discover and develop endogenous regenerative medicines to repair and regenerate tissues | endogena’s …See details»
Endogena Therapeutics AG - Swiss Biotech
Endogena is a clinical-stage biotechnology company that discovers and develops first-in-class endogenous regenerative medicines to repair diseased tissues. Our unique approach has the …See details»
Endogena Therapeutics - BIO CEO & Investor Conference | BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... Endogena Therapeutics …See details»
Endogena Completes Series A with Total Funding of $29 million to ...
Jun 4, 2022 Rejuveron is focused on advancing treatments that focus on the biology of ageing and Endogena has transformative potential for age-related degenerative diseases. …See details»
Endogena - Contacts, Employees, Board Members, Advisors
Endogena is a biotech company that develops endogenous regenerative medicines to repair and regenerate tissues and organs.See details»
Rejuveron Increases to Near-majority Stake in Endogena Through …
Dec 13, 2021 In January, Rejuveron already provided $4.75 million as part of Endogena's $8m series A-1 financing round and is the largest shareholder in Endogena, alongside major …See details»
Moreno Menghini appointed chief medical officer – endogena …
Jun 4, 2022 endogena therapeutics inc. 111 pine street san francisco | ca 94111 usa +1 (415) 594-0594. Contact. endogena therapeutics ag binzmühlestrasse 170 d 8050 zürich …See details»
Endogena Completes Series A with Total Funding of $29 million to ...
Dec 13, 2021 In January, Rejuveron already provided $4.75 million as part of Endogena’s $8m series A-1 financing round and is the largest shareholder in Endogena, alongside major …See details»
Rejuveron Increases to Near-majority Stake in Endogena Through …
Dec 12, 2021 Endogena’s novel, small-molecule approach is gene-independent, which has significant advantages in this condition that has multiple genetic causes. It leverages an …See details»
Endogena - workinbiotech.com
Endogena Therapeutics is focused on developing innovative treatments for rare and degenerative diseases related to aging and genetic disorders. Their unique approach involves harnessing …See details»
Endogena starts clinical trials for regenerative treatment for …
Jul 18, 2022 Endogena Therapeutics Inc. is a clinical-stage biotech company that discovers and develops first-in-class endogenous regenerative medicines to repair and regenerate tissues …See details»
news – endogena therapeutics
Endogena therapeutics inc. 111 pine street san francisco | ca 94111 usa +1 (415) 594-0594See details»
Endogena Therapeutics Secures FDA Green Light for
Oct 24, 2023 Endogena Therapeutics Inc. is a clinical-stage biotech company that discovers and develops first-in-class endogenous regenerative medicines to repair and regenerate tissues …See details»
Endogena Therapeutics Completes Dose Escalation in the Phase …
Apr 5, 2023 Endogena Therapeutics Inc., a clinical-stage biotech company focused on the development of endogenous regenerative medicines, announced today that the dose …See details»
Enamine and Endogena Therapeutics - Business Wire
Apr 19, 2023 Endogena Therapeutics Inc. is a clinical-stage biotech company that discovers and develops first-in-class endogenous regenerative medicines to repair and regenerate tissues …See details»
Endogena receives Retina Innovation Award at event showcasing …
Aug 9, 2022 A total of 31 companies had been selected to present their latest clinical data at the event, with Endogena receiving the Retina Innovation Award in recognition for its lead product, …See details»